recurrent grade 1 follicular lymphoma

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

Active, not recruiting
  • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
  • +18 more
  • Anti-ICOS Monoclonal Antibody MEDI-570
  • +2 more
  • Duarte, California
  • +22 more
Jan 18, 2023

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +45 more
  • anti-endosialin/TEM1 monoclonal antibody MORAb-004
  • +2 more
  • Birmingham, Alabama
  • +19 more
Jan 7, 2016

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +50 more
  • Akt inhibitor MK2206
  • +2 more
  • Birmingham, Alabama
  • +24 more
Apr 28, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
Mar 14, 2014

Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma Trial in

Completed
  • Recurrent Grade 1 Follicular Lymphoma
  • +3 more
  • Chicago, Illinois
    Cancer and Leukemia Group B (CALGB) Research Base
Jan 4, 2013